What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Antibody
Jean-Gérard Guillet spends much of his time researching Virology, Epitope, Immunology, Immune system and CTL*.
The study incorporates disciplines such as Autoantibody, Autoimmune disease, Capsid, Receptor and Peptide in addition to Epitope.
His Immunology research integrates issues from Beta-1 adrenergic receptor and Breast cancer.
His work deals with themes such as Adenoviridae, Recombinant DNA and Antibody, which intersect with Immune system.
His study with CTL* involves better knowledge in Cytotoxic T cell.
His studies deal with areas such as T cell, CD8, Molecular biology and Virus as well as Cytotoxic T cell.
His most cited work include:
- HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance (375 citations)
- Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. (291 citations)
- HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. (268 citations)
What are the main themes of his work throughout his whole career to date?
Jean-Gérard Guillet mostly deals with Immunology, Virology, Epitope, Cytotoxic T cell and CD8.
His Virology research is multidisciplinary, incorporating perspectives in Immunopathology and Immunogenicity.
His work carried out in the field of Epitope brings together such families of science as Molecular biology, Human leukocyte antigen, Lipopeptide, CTL* and Major histocompatibility complex.
His Molecular biology research incorporates themes from In vivo, Antibody, Antigen presentation and Antigen.
His research investigates the connection between Cytotoxic T cell and topics such as T cell that intersect with issues in Interleukin 2.
His CD8 research focuses on Melanoma and how it relates to Metastasis.
He most often published in these fields:
- Immunology (47.40%)
- Virology (41.04%)
- Epitope (36.99%)
What were the highlights of his more recent work (between 2004-2014)?
- Immunology (47.40%)
- Virology (41.04%)
- CD8 (32.95%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Immunology, Virology, CD8, Cytotoxic T cell and T cell.
The Immunology study which covers HIV vaccine that intersects with Lentivirus, Simian immunodeficiency virus and Virus.
The Virology study combines topics in areas such as Lipopeptide, Anti hiv 1 and Synthetic gene.
The concepts of his CD8 study are interwoven with issues in Epitope and Major histocompatibility complex.
His Epitope research is multidisciplinary, relying on both Human leukocyte antigen and Peptide.
His research ties Immunotherapy and Cytotoxic T cell together.
Between 2004 and 2014, his most popular works were:
- Antigen crosspresentation by human plasmacytoid dendritic cells. (224 citations)
- Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients (117 citations)
- Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients. (106 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Antibody
His main research concerns Immunology, CD8, Cytotoxic T cell, T cell and Major histocompatibility complex.
Many of his studies involve connections with topics such as Lipopeptide and Immunology.
His CD8 study combines topics from a wide range of disciplines, such as Antigen presentation and Endosome.
ELISPOT is the focus of his Cytotoxic T cell research.
His research integrates issues of Phagocytosis, Cell biology, Myeloid, HIV Antigens and Antigen in his study of T cell.
His research in Epitope intersects with topics in Multiple sclerosis, Human leukocyte antigen, Immunity and T-cell receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
